Trials / Withdrawn
WithdrawnNCT00427258
Study Evaluating MOA-728 Administered in Healthy Men
An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]MOA-728 in Healthy Men
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Absorption, distribution, metabolism, and excretion (ADME) study with 14C in healthy young men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MOA-728 |
Timeline
- Start date
- 2010-01-01
- First posted
- 2007-01-29
- Last updated
- 2019-11-29
Source: ClinicalTrials.gov record NCT00427258. Inclusion in this directory is not an endorsement.